These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5804723)

  • 41. The genome of non-O1 Vibrio cholerae NRT36S demonstrates the presence of pathogenic mechanisms that are distinct from those of O1 Vibrio cholerae.
    Chen Y; Johnson JA; Pusch GD; Morris JG; Stine OC
    Infect Immun; 2007 May; 75(5):2645-7. PubMed ID: 17283087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neuraminidase activity, hemolysin, permeability factor and lethal toxin in filtrates of halophilic sea vibrios].
    Rottini G; Tamaro M; di Filippo L
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):318-23. PubMed ID: 4145838
    [No Abstract]   [Full Text] [Related]  

  • 43. Experimental Toxigenicity of NAG Vibrios.
    Draskovicová M; Karolcek J; Winkler
    Zentralbl Bakteriol Orig A; 1977 Feb; 237(1):65-71. PubMed ID: 842178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vibrio mimicus with multiple toxin types isolated from human and environmental sources.
    Ramamurthy T; Albert MJ; Huq A; Colwell RR; Takeda Y; Takeda T; Shimada T; Mandal BK; Nair GB
    J Med Microbiol; 1994 Mar; 40(3):194-6. PubMed ID: 8114069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of environmental and clinical isolates of Vibrio mimicus from Vibrio cholerae by multilocus enzyme electrophoresis.
    Vieira VV; Teixeira LF; Vicente AC; Momen H; Salles CA
    Appl Environ Microbiol; 2001 May; 67(5):2360-4. PubMed ID: 11319123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of gastrointestinal enzymes on cholera toxin.
    Dutta NK; Oza NB
    Bull World Health Organ; 1963; 28(3):307-10. PubMed ID: 20604142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The use of a CHO cell culture in studying Vibrio cholerae grown under different conditions].
    Sal'nikova OI; Lobanov VV; Shimaniuk NIa
    Mikrobiol Zh (1978); 1991; 53(6):94-8. PubMed ID: 1726445
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of vibrio El Tor toxin in a liquid medium.
    WATANABE Y; FELSENFELD O
    J Bacteriol; 1961 Jul; 82(1):43-7. PubMed ID: 13783348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved purification process for cholera toxin and its application to the quantification of residual toxin in cholera vaccines.
    Jang H; Kim HS; Kim JA; Seo JH; Carbis R
    J Microbiol Biotechnol; 2009 Jan; 19(1):108-12. PubMed ID: 19190416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholera toxin: effect of splenectomy and immunosuppressive drug on the permeability factor: preliminary report.
    Ghosh AK; Bhattacharya S; Majumder RN
    Indian J Med Res; 1974 Feb; 62(2):169-73. PubMed ID: 4442959
    [No Abstract]   [Full Text] [Related]  

  • 51. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.
    Benenson AS; Saad A; Mosley WH; Ahmed A
    Bull World Health Organ; 1968; 38(2):287-95. PubMed ID: 5302304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fine structure of Vibrio cholerae during toxin production.
    Kennedy JR; Richardson SH
    J Bacteriol; 1969 Dec; 100(3):1393-401. PubMed ID: 5361220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholera toxin and toxoid.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    Prog Immunobiol Stand; 1971; 5():348-9. PubMed ID: 4660540
    [No Abstract]   [Full Text] [Related]  

  • 54. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
    Fasano A; Baudry B; Pumplin DW; Wasserman SS; Tall BD; Ketley JM; Kaper JB
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5242-6. PubMed ID: 2052603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental studies on cholera immunization. 1. The response of neutralizing and vibriocidal antibodies in rabbits after immunization with culture filtrate material from V. cholerae.
    Holmgren J; Svennerholm AM; Ouchterlony O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1972; 80(4):489-96. PubMed ID: 4509186
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of metal ions on the production of vascular permeability factor by 569B strain of Vibrio cholerae.
    Sagar IK; Nagesha CN; Bhat JV
    Indian J Med Res; 1979 Jan; 69():18-25. PubMed ID: 429022
    [No Abstract]   [Full Text] [Related]  

  • 57. [Characterization of monoclonal antibodies that recognize the thermolabile toxin of Vibrio cholerae].
    González Garriga M; García Sánchez HM; Hermida Díaz C; Marcet Sánchez R; Monté Boada R
    Rev Cubana Med Trop; 1992; 44(3):185-7. PubMed ID: 9768213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characteristics of the exotoxin from cholera vibrio El Tor].
    Korovkina GV; Kozarenko TD; Pugacheva NN; Urbanovich LIa; Karetnikova ES
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Nov; 50(11):50-4. PubMed ID: 4593077
    [No Abstract]   [Full Text] [Related]  

  • 59. On the similarity of tetanus and cholera toxins.
    van Heyningen WE
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(3-4):289-95. PubMed ID: 4268160
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors influencing in vitro skin permeability factor production by Vibrio cholerae.
    Richardson SH
    J Bacteriol; 1969 Oct; 100(1):27-34. PubMed ID: 5344097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.